Sonnet BioTherapeutics
SONN
SONN
11 hedge funds and large institutions have $1.08M invested in Sonnet BioTherapeutics in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BIT
1
BlackRock Institutional Trust
San Francisco,
California
|
$85K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Millennium Management
New York
| $383K | 222,222 | – | – |
|
|
TDC
2
Thompson Davis & Co
Richmond,
Virginia
| $358K | 207,387 | +13,999 | +7% |
|
|
BIT
3
BlackRock Institutional Trust
San Francisco,
California
| $85K | 49,066 | -7,626 | -13% |
|
|
CDH
4
Charles D. Hyman
| $77K | 44,444 | – | – |
|
|
VKH
5
Virtu KCG Holdings
New York
| $74K | 42,626 | +42,626 | New |
|
|
WA
6
WFG Advisors
Dallas,
Texas
| $40K | 23,332 | – | – |
|
7
Bank of America
Charlotte,
North Carolina
| $37K | 21,428 | – | – |
|
8
Neuberger Berman Group
New York
| $22K | 13,000 | +13,000 | New |
|
9
UBS Group
Zurich,
Switzerland
| $3K | 2,000 | +2,000 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $1K | 380 | +119 | +46% |
|
11
Morgan Stanley
New York
| $0 | 12 | +1 | +9% |
|